文献速递中枢神经肿瘤放疗放疗物理与技术

表面引导放疗联合肿瘤治疗电场治疗胶质母细胞瘤的可行性初步研究:感兴趣区

Preliminary study of feasibility of surface-guided radiotherapy with concurrent tumor treating fields for glioblastoma: region of interest.
PubMed 文献 · Radiat Oncol · 2024-09-27

本研究纳入15例接受放疗联合肿瘤治疗电场(TTFields)的胶质母细胞瘤患者,定义四种形状的感兴趣区(ROI),利用头颈部体模以CBCT为参考评估六自由度残余摆位误差,并基于几何变换方法将误差转换为15例放疗计划的剂量学偏差。结果显示表面引导摆位在同步TTFields放疗中可行,中等大小T形ROI适合用于表面引导。

要点

  • 四种ROI形状的六自由度平均残余摆位误差代数和分别为6.9、1.1、4.1和3.5。
  • 不同ROI形状下PTV的D98%分别下降(3.4±2.0)%、(0.3±0.5)%、(0.9±0.9)%和(1.1±0.8)%(均p<0.05)。
  • 条状ROI下CTV的D98%下降(0.5±0.6)%(p<0.05),其他ROI形状下保持不变。

核心结论

  • 表面引导摆位在放疗联合TTFields中可行,中等大小T形ROI适合用于表面引导。

研究设计与样本

  • 纳入15例接受放疗联合TTFields的胶质母细胞瘤患者,定义四种形状(条状、T形、⊥形和十字形)且相对于全脸为中等大小的ROI,使用头颈部体模以CBCT数据为参考评估六自由度残余摆位误差,并用基于几何变换的方法将误差转换为15例放疗计划的剂量学偏差。

主要发现

  • 四种ROI形状的六自由度平均残余摆位误差代数和分别为6.9、1.1、4.1和3.5(平移方向单位为mm,旋转方向单位为°)。
  • PTV的D98%分别下降(3.4±2.0)%(p<0.05)、(0.3±0.5)%(p<0.05)、(0.9±0.9)%(p<0.05)和(1.1±0.8)%(p<0.05)。
  • 条状ROI下CTV的D98%下降(0.5±0.6)%(p<0.05),其他ROI形状下CTV的D98%保持不变。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the impact of the residual setup errors from differently shaped region of interest (ROI) and investigate if surface-guided setup can be used in radiotherapy with concurrent tumor treating fields (TTFields) for glioblastoma. METHODS: Fifteen patients undergone glioblastoma radiotherapy with concurrent TTFields were involved. Firstly, four shapes of region of interest (ROI) (strip-shaped, T-shaped, ⊥ -shaped and cross-shaped) with medium size relative to the whole face were defined dedicate for patients wearing TTFields transducer arrays. Then, ROI-shape-dependent residual setup errors in six degrees were evaluated using an anthropomorphic head and neck phantom taking CBCT data as reference. Finally, the four types of residual setup errors were converted into corresponding dosimetry deviations (including the target coverage and the organ at risk sparing) of the fifteen radiotherapy plans using a feasible and robust geometric-transform-based method. RESULTS: The algebraic sum of the average residual setup errors in six degrees (mm in translational directions and ° in rotational directions) of the four types were 6.9, 1.1, 4.1 and 3.5 respectively. In terms of the ROI-shape-dependent dosimetry deviations, the D98% of PTV dropped off by (3.4 ± 2.0)% (p < 0.05), (0.3 ± 0.5)% (p < 0.05), (0.9 ± 0.9)% (p < 0.05) and (1.1 ± 0.8)% (p < 0.05). The D98% of CTV dropped off by (0.5 ± 0.6)% (p < 0.05) for the strip-shaped ROI while remained unchanged for others. CONCLUSION: Surface-guided setup is feasible in radiotherapy with concurrent TTFields and a medium-sized T-shaped ROI is appropriate for the surface-based guidance.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Zheng J, Xu G, Guo W, et al. Preliminary study of feasibility of surface-guided radiotherapy with concurrent tumor treating fields for glioblastoma: region of interest. Radiat Oncol. 2024. PMID: 39334165. doi:10.1186/s13014-024-02525-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。